Thermo Fisher Scientific, Inc. (TMO)
509.82
-17.35
(-3.29%)
USD |
NYSE |
Feb 12, 16:00
508.80
-1.02
(-0.20%)
Pre-Market: 08:10
Thermo Fisher Scientific Cash from Investing (Quarterly) : 891.00M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Sotera Health Co. | -33.34M |
| Veracyte, Inc. | 48.26M |
| Danaher Corp. | -384.00M |
| FONAR Corp. | -2.367M |
| Eli Lilly & Co. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.458B |
| Cash from Financing (Quarterly) | 3.526B |
| Free Cash Flow | 6.294B |
| Free Cash Flow Per Share (Quarterly) | 7.939 |
| Free Cash Flow to Equity (Quarterly) | -712.00M |
| Free Cash Flow to Firm (Quarterly) | 3.332B |
| Free Cash Flow Yield | 3.27% |